214 related articles for article (PubMed ID: 29341398)
1. What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?
Croome KP; Lee DD; Pungpapong S; Keaveny AP; Taner CB
Liver Transpl; 2018 Apr; 24(4):497-504. PubMed ID: 29341398
[TBL] [Abstract][Full Text] [Related]
2. Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
Jackson KR; Bowring MG; Holscher C; Haugen CE; Long JJ; Liyanage L; Massie AB; Ottmann S; Philosophe B; Cameron AM; Segev DL; Garonzik-Wang J
Transplantation; 2020 Aug; 104(8):1612-1618. PubMed ID: 32732838
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC
Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630
[TBL] [Abstract][Full Text] [Related]
4. Variability in acceptance of organ offers by pediatric transplant centers and its impact on wait-list mortality.
Mitchell E; Loomes KM; Squires RH; Goldberg D
Liver Transpl; 2018 Jun; 24(6):803-809. PubMed ID: 29506323
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation in the United Kingdom.
Neuberger J
Liver Transpl; 2016 Aug; 22(8):1129-35. PubMed ID: 27081833
[TBL] [Abstract][Full Text] [Related]
6. Optimizing the Use of Geriatric Livers for Transplantation in the Eurotransplant Region.
de Boer JD; Blok JJ; Putter H; Koopman JJE; van Hoek B; Samuel U; van Rosmalen M; Metselaar HJ; Alwayn IPJ; Guba M; Braat AE;
Liver Transpl; 2019 Feb; 25(2):260-274. PubMed ID: 30317683
[TBL] [Abstract][Full Text] [Related]
7. Offer acceptance practices and geographic variability in allocation model for end-stage liver disease at transplant.
Wey A; Pyke J; Schladt DP; Gentry SE; Weaver T; Salkowski N; Kasiske BL; Israni AK; Snyder JJ
Liver Transpl; 2018 Apr; 24(4):478-487. PubMed ID: 29316203
[TBL] [Abstract][Full Text] [Related]
8. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
9. Combined Dual-Kidney Liver Transplantation in the United States: A Review of United Network for Organ Sharing/Organ Procurement and Transplantation Network Data Between 2002 and 2012.
Shekhtman G; Huang E; Danovitch GM; Martin P; Bunnapradist S
Liver Transpl; 2018 Nov; 24(11):1570-1577. PubMed ID: 29493877
[TBL] [Abstract][Full Text] [Related]
10. Outcomes for potential kidney transplant recipients offered public health service increased risk kidneys: A single-center experience.
Fernandez HE; Chiles MC; Pereira M; Husain SA; Miko B; Baral P; Dale LA; Patel S; Runge B; Tsapepas D; Sandoval PR; Ratner LE; Cohen DJ; Mohan S
Clin Transplant; 2018 Dec; 32(12):e13427. PubMed ID: 30329179
[TBL] [Abstract][Full Text] [Related]
11. National Variation in Increased Infectious Risk Kidney Offer Acceptance.
Holscher CM; Bowring MG; Haugen CE; Zhou S; Massie AB; Gentry SE; Segev DL; Garonzik Wang JM
Transplantation; 2019 Oct; 103(10):2157-2163. PubMed ID: 31343577
[TBL] [Abstract][Full Text] [Related]
12. Attitudes of Liver Transplant Candidates Toward Organs From Increased-Risk Donors.
Humar SS; Liu J; Pinzon N; Kumar D; Bhat M; Lilly L; Selzner N
Liver Transpl; 2019 Jun; 25(6):881-888. PubMed ID: 30947392
[TBL] [Abstract][Full Text] [Related]
13. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
[TBL] [Abstract][Full Text] [Related]
14. Maximizing donors with viral hepatitis in the current era.
Brown K
Liver Transpl; 2017 Oct; 23(S1):S44-S49. PubMed ID: 28846183
[No Abstract] [Full Text] [Related]
15. Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?
Selzner N; Berenguer M
Liver Transpl; 2018 Jun; 24(6):831-840. PubMed ID: 29624894
[TBL] [Abstract][Full Text] [Related]
16. Survival implications of opioid use before and after liver transplantation.
Randall HB; Alhamad T; Schnitzler MA; Zhang Z; Ford-Glanton S; Axelrod DA; Segev DL; Kasiske BL; Hess GP; Yuan H; Ouseph R; Lentine KL
Liver Transpl; 2017 Mar; 23(3):305-314. PubMed ID: 28027603
[TBL] [Abstract][Full Text] [Related]
17. Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation.
Cox ML; Mulvihill MS; Choi AY; Bishawi M; Osho AA; Haney JC; Daneshmand M; Klapper JA; Wolfe CR; Hartwig M
J Heart Lung Transplant; 2019 Mar; 38(3):295-305. PubMed ID: 30773195
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation in Germany.
Tacke F; Kroy DC; Barreiros AP; Neumann UP
Liver Transpl; 2016 Aug; 22(8):1136-42. PubMed ID: 27082951
[TBL] [Abstract][Full Text] [Related]
19. A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation.
Leung DH; Narang A; Minard CG; Hiremath G; Goss JA; Shepherd R
Liver Transpl; 2016 Nov; 22(11):1584-1592. PubMed ID: 27541809
[TBL] [Abstract][Full Text] [Related]
20. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
Pruett TL; Clark MA; Taranto SE
Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
